Roivant Sciences Ltd. (ROIV) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2026 | $1.42B | -47.7% |
| 2025 | $2.72B | -58.2% |
| 2024 | $6.49B | +287.3% |
| 2023 | $1.68B | -18.6% |
| 2022 | $2.06B | +0.3% |
| 2021 | $2.06B | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2026 | $1.42B | -47.7% |
| 2025 | $2.72B | -58.2% |
| 2024 | $6.49B | +287.3% |
| 2023 | $1.68B | -18.6% |
| 2022 | $2.06B | +0.3% |
| 2021 | $2.06B | — |